Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4925 |  HCWB HCW Biologics Inc. - Common Stock | 1.53 USD | -1.92% | -7.83% | -36.51% | +146.77% | 2.81 M USD | ||
| 4928 |  MTNB Matinas Biopharma Holdings, Inc. Common Stock | 2.79 USD | +2.57% | +8.14% | +1450.00% | +350.00% | 2.73 M USD | ||
| 4931 |  CLDI Calidi Biotherapeutics, Inc. Common Stock | 1.04 USD | +1.96% | -1.89% | -20.61% | +36.84% | 2.69 M USD | ||
| 4933 |  CANF Can-Fite Biopharma Ltd American Depositary Shares, each represe | 2.04 USD | -3.77% | -7.27% | -8.11% | -53.21% | 2.67 M USD | ||
| 4935 |  XRTX XORTX Therapeutics Inc. - Common Shares | 1.85 USD | +5.71% | +7.56% | -24.49% | +103.30% | 2.58 M USD | ||
| 4936 |  ONCO Onconetix, Inc. - Common Stock | 0.65 USD | +8.33% | -12.16% | -20.73% | -14.47% | 2.57 M USD | ||
| 4940 |  ELAB PMGC Holdings Inc. - Common Stock | 3.11 USD | -2.51% | -7.16% | -32.68% | +130.37% | 2.52 M USD | ||
| 4942 |  BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 USD | -15.62% | -15.25% | -32.98% | +9.88% | 2.41 M USD | ||
| 4948 |  SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 1.45 USD | +0.69% | -3.33% | -39.33% | +116.42% | 2.30 M USD | ||
| 4951 |  GNPX Genprex, Inc. - Common Stock | 2.75 USD | +4.96% | +7.42% | -18.64% | +47.06% | 2.25 M USD | ||
| 4960 |  OGEN Oragenics Inc. Common Stock | 0.48 USD | -4.00% | 0.00% | -5.88% | -23.81% | 2.17 M USD | ||
| 4963 |  GOVX GeoVax Labs, Inc. - Common Stock | 0.29 USD | 0.00% | -9.38% | -40.82% | -80.00% | 2.14 M USD | ||
| 4964 |  JUNS Jupiter Neurosciences, Inc. - Common Stock | 2.77 USD | -2.46% | +9.06% | -12.06% | +385.96% | 2.13 M USD | ||
| 4970 |  TCRT Alaunos Therapeutics, Inc. - Common Stock | 0.78 USD | -7.14% | -13.33% | -48.68% | -70.79% | 1.98 M USD | ||
| 4982 |  ARTL Artelo Biosciences, Inc. - Common Stock | 3.37 USD | -1.17% | -12.47% | -43.83% | +180.83% | 1.72 M USD | ||
| 4990 |  SPRC SciSparc Ltd. - Ordinary Shares | 4.43 USD | -4.53% | -3.06% | -8.28% | +0.68% | 1.62 M USD | ||
| 4991 |  JAGX Jaguar Health, Inc. - Common Stock | 4.53 USD | -9.40% | +8.89% | +1124.32% | +630.65% | 1.56 M USD | ||
| 4993 |  CRIS Curis, Inc. - Common Stock | 0.71 USD | -4.05% | -12.35% | -41.32% | -56.17% | 1.48 M USD | ||
| 4998 |  IMMP Immutep Limited - American Depositary Shares | 3.84 USD | -6.57% | -14.48% | +966.67% | +85.51% | 1.40 M USD | ||
| 5000 |  PPBT Purple Biotech Ltd - American Depositary Shares | 1.44 USD | -1.37% | +1.41% | -22.16% | +148.28% | 1.34 M USD |
Noticias Biotechnology Stocks
El fármaco de Pharvaris para el angioedema hereditario muestra alivio más rápido
Raymond James inicia cobertura de Kymera Therapeutics con Mejor Rendimiento
Raymond James inicia cobertura de Nektar con calificación de rendimiento de mercado
Palisade Bio inicia cobertura con Mejor Rendimiento según Raymond James
Raymond James reitera su calificación de Liquidia en medio de presentaciones legales
Tenax Therapeutics pausa temporalmente la inscripción en el ensayo LEVEL-2 de TNX-103 para modificar los criterios; solicita reunión con la FDA
Ginkgo Bioworks apoyará a los X-Labs de la NSF con acceso a su laboratorio
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |